RPA2 and neoplasm: In the whole cohort, Low RPA2 mRNA was significantly associated with poor overall survival in the whole cohort (P < 0.0001) (Fig. 2G), in ER + tumours (P < 0.0001) (Supplementary Fig. 4D) and ER- tumours (P = 0.013) (Supplementary Fig. 4E).